---
title: "Guangxi Wuzhou Zhongheng Group Co., Ltd. (600252.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600252.SH.md"
symbol: "600252.SH"
name: "Guangxi Wuzhou Zhongheng Group Co., Ltd."
industry: "Pharmaceuticals"
datetime: "2026-05-20T22:42:47.928Z"
locales:
  - [en](https://longbridge.com/en/quote/600252.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600252.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600252.SH.md)
---

# Guangxi Wuzhou Zhongheng Group Co., Ltd. (600252.SH)

## Company Overview

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and other healthcare applications. It also provides clindamycin hydrochloride injection, esomeprazole sodium injection, esomeprazole magnesium enteric-coated capsules, cefoperazone dry suspension, naloxone hydrochloride injection, and fludarabine phosphate injection. Further, the company is involved in production of oral care, clothing care, and home care products, including toothpaste; health food business; pharmaceutical distribution; project investment and management; real estate development and operation; and cosmetic products businesses.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.wz-zhongheng.com](https://www.wz-zhongheng.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: D (0.69)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 188 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -28.32% |  |
| Net Profit YoY | 1.30% |  |
| P/B Ratio | 1.39 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 7336601544.34 |  |
| Revenue | 1584674376.37 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -7.25% | D |
| Profit Margin | -25.80% | E |
| Gross Margin | 52.85% | B |
| Revenue YoY | -28.32% | E |
| Net Profit YoY | 1.30% | C |
| Total Assets YoY | -6.27% | D |
| Net Assets YoY | -11.26% | E |
| Cash Flow Margin | -16.62% | D |
| OCF YoY | -28.32% | E |
| Turnover | 0.15 | D |
| Gearing Ratio | 35.52% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Guangxi Wuzhou Zhongheng Group Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-28.32%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "1.30%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.39",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "7336601544.34",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1584674376.37",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-7.25%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-25.80%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "52.85%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-28.32%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "1.30%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-6.27%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-11.26%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-16.62%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-28.32%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.15",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "35.52%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -17.56 | 184/215 | - | - | - |
| PB | 1.36 | 30/215 | 1.58 | 1.50 | 1.43 |
| PS (TTM) | 4.53 | 122/215 | 4.23 | 3.88 | 3.71 |
| Dividend Yield | 0.00% | - | 0.41% | 0.40% | 0.39% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/600252.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/600252.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/600252.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/600252.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**